Dispersome® Technology
Product Description
Zerion Pharma
-
Country/Region:Denmark
-
On CPHI since:2021
-
Employees:1 - 24
Company types
Categories
Zerion Pharma
-
Country/Region:Denmark
-
On CPHI since:2021
-
Employees:1 - 24
Company types
Zerion Pharma resources (13)
-
Brochure Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement
Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement for beta-lactoglobulin (Lacprodan® BLG-100) -
Video Dispersome® – an amorphous mixture
Technology that is changing the future
DISPERSOME®️ PLATFORM
Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.
IMPROVING OUTCOMESBy increasing solubility and dissolution rate the Dispersome®️ platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.
COMPATIBLE TECHNOLOGY
Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.
.png)